-
1
-
-
84878323916
-
Accounting for tumor heterogeneity in the development of predictive biomarkers
-
[PubMed]
-
Siu, L.L.: Accounting for tumor heterogeneity in the development of predictive biomarkers. Clin. Adv. Hematol. Oncol. 2013, 11, 312–313. [PubMed]
-
(2013)
Clin. Adv. Hematol. Oncol
, vol.11
, pp. 312-313
-
-
Siu, L.L.1
-
2
-
-
84938197903
-
Next-generation sequencing to guide cancer therapy
-
[CrossRef] [PubMed]
-
Gagan, J.; van Allen, E.M. Next-generation sequencing to guide cancer therapy. Genome Med. 2015, 7, 80. [CrossRef] [PubMed]
-
(2015)
Genome Med
, vol.7
, pp. 80
-
-
Gagan, J.1
Van Allen, E.M.2
-
3
-
-
77953565979
-
Gene-expression-based prognostic assays for breast cancer
-
[CrossRef] [PubMed]
-
Kim, C.; Paik, S. Gene-expression-based prognostic assays for breast cancer. Nat. Rev. Clin. Oncol. 2010, 7, 340–347. [CrossRef] [PubMed]
-
(2010)
Nat. Rev. Clin. Oncol
, vol.7
, pp. 340-347
-
-
Kim, C.1
Paik, S.2
-
4
-
-
84900298544
-
Tumor signatures in the blood
-
[CrossRef] [PubMed]
-
Speicher, M.R.; Pantel, K. Tumor signatures in the blood. Nat. Biotechnol. 2014, 32, 441–443. [CrossRef] [PubMed]
-
(2014)
Nat. Biotechnol
, vol.32
, pp. 441-443
-
-
Speicher, M.R.1
Pantel, K.2
-
5
-
-
84872017586
-
Circulating tumor cells: Liquid biopsy of cancer
-
[CrossRef] [PubMed]
-
Alix-Panabieres, C.; Pantel, K. Circulating tumor cells: Liquid biopsy of cancer. Clin. Chem. 2013, 59, 110–118. [CrossRef] [PubMed]
-
(2013)
Clin. Chem
, vol.59
, pp. 110-118
-
-
Alix-Panabieres, C.1
Pantel, K.2
-
6
-
-
84880270290
-
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
-
[CrossRef] [PubMed]
-
Baccelli, I.; Schneeweiss, A.; Riethdorf, S.; Stenzinger, A.; Schillert, A.; Vogel, V.; Klein, C.; Saini, M.; Bauerle, T.; Wallwiener, M. et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat. Biotechnol. 2013, 31, 539–544. [CrossRef] [PubMed]
-
(2013)
Nat. Biotechnol
, vol.31
, pp. 539-544
-
-
Baccelli, I.1
Schneeweiss, A.2
Riethdorf, S.3
Stenzinger, A.4
Schillert, A.5
Vogel, V.6
Klein, C.7
Saini, M.8
Bauerle, T.9
Wallwiener, M.10
-
7
-
-
84877726784
-
The identification and characterization of breast cancer CTCs competent for brain metastasis
-
[CrossRef] [PubMed]
-
Zhang, L.; Ridgway, L.D.; Wetzel, M.D.; Ngo, J.; Yin, W.; Kumar, D.; Goodman, J.C.; Groves, M.D.; Marchetti, D. The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci. Transl. Med. 2013, 5, 180ra48. [CrossRef] [PubMed]
-
(2013)
Sci. Transl. Med
, vol.5
-
-
Zhang, L.1
Ridgway, L.D.2
Wetzel, M.D.3
Ngo, J.4
Yin, W.5
Kumar, D.6
Goodman, J.C.7
Groves, M.D.8
Marchetti, D.9
-
8
-
-
4143094988
-
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
-
[CrossRef] [PubMed]
-
Cristofanilli, M.; Budd, G.T.; Ellis, M.J.; Stopeck, A.; Matera, J.; Miller, M.C.; Reuben, J.M.; Doyle, G.V.; Allard, W.J.; Terstappen, L.W. et al.: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 2004, 351, 781–791. [CrossRef] [PubMed]
-
(2004)
N. Engl. J. Med
, vol.351
, pp. 781-791
-
-
Cristofanilli, M.1
Budd, G.T.2
Ellis, M.J.3
Stopeck, A.4
Matera, J.5
Miller, M.C.6
Reuben, J.M.7
Doyle, G.V.8
Allard, W.J.9
Terstappen, L.W.10
-
9
-
-
0030728470
-
Application of immunomagnetic beads in combination with RT-PCR for the detection of circulating prostate cancer cells
-
[CrossRef]
-
Makarovskiy, A.N.; Ackerley, W., III; Wojcik, L.; Halpert, G.K.; Stein, B.S.; Carreiro, M.P.; Hixson, D.C. Application of immunomagnetic beads in combination with RT-PCR for the detection of circulating prostate cancer cells. J. Clin. Lab. Anal. 1997, 11, 346–350. [CrossRef]
-
(1997)
J. Clin. Lab. Anal
, vol.11
, pp. 346-350
-
-
Makarovskiy, A.N.1
Ackerley, W.2
Wojcik, L.3
Halpert, G.K.4
Stein, B.S.5
Carreiro, M.P.6
Hixson, D.C.7
-
10
-
-
6044259206
-
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
-
[CrossRef] [PubMed]
-
Allard, W.J.; Matera, J.; Miller, M.C.; Repollet, M.; Connelly, M.C.; Rao, C.; Tibbe, A.G.; Uhr, J.W.; Terstappen, L.W. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 2004, 10, 6897–6904. [CrossRef] [PubMed]
-
(2004)
Clin. Cancer Res
, vol.10
, pp. 6897-6904
-
-
Allard, W.J.1
Matera, J.2
Miller, M.C.3
Repollet, M.4
Connelly, M.C.5
Rao, C.6
Tibbe, A.G.7
Uhr, J.W.8
Terstappen, L.W.9
-
11
-
-
33947510399
-
Detection of circulating urothelial cancer cells in the blood using the Cell Search System
-
[CrossRef] [PubMed]
-
Naoe, M.; Ogawa, Y.; Morita, J.; Omori, K.; Takeshita, K.; Shichijyo, T.; Okumura, T.; Igarashi, A.; Yanaihara, A.; Iwamoto, S. et al. Detection of circulating urothelial cancer cells in the blood using the Cell Search System. Cancer 2007, 109, 1439–1445. [CrossRef] [PubMed]
-
(2007)
Cancer
, vol.109
, pp. 1439-1445
-
-
Naoe, M.1
Ogawa, Y.2
Morita, J.3
Omori, K.4
Takeshita, K.5
Shichijyo, T.6
Okumura, T.7
Igarashi, A.8
Yanaihara, A.9
Iwamoto, S.10
-
12
-
-
24344484110
-
Detection and clinical implications of minimal residual disease in gastro-intestinal cancer
-
[CrossRef] [PubMed]
-
Wolfrum, F.; Vogel, I.; Fandrich, F.; Kalthoff, H.: Detection and clinical implications of minimal residual disease in gastro-intestinal cancer. Langenbecks Arch. Surg. 2005, 390, 430–441. [CrossRef] [PubMed]
-
(2005)
Langenbecks Arch. Surg
, vol.390
, pp. 430-441
-
-
Wolfrum, F.1
Vogel, I.2
Fandrich, F.3
Kalthoff, H.4
-
13
-
-
0027420725
-
Detection and enumeration of circulating tumour cells in colorectal cancer
-
[CrossRef] [PubMed]
-
Choy, A.; McCulloch, P.G. Detection and enumeration of circulating tumour cells in colorectal cancer. Br. J. Surg. 1993, 80, 1490. [CrossRef] [PubMed]
-
(1993)
Br. J. Surg
, vol.80
, pp. 1490
-
-
Choy, A.1
McCulloch, P.G.2
-
14
-
-
0036674501
-
Dissemination and growth of cancer cells in metastatic sites
-
[CrossRef] [PubMed]
-
Chambers, A.F.; Groom, A.C.; MacDonald, I.C.: Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2002, 2, 563–572. [CrossRef] [PubMed]
-
(2002)
Nat. Rev. Cancer
, vol.2
, pp. 563-572
-
-
Chambers, A.F.1
Groom, A.C.2
Macdonald, I.C.3
-
15
-
-
75849140296
-
Circulating tumor cells: A window into cancer biology and metastasis
-
[CrossRef] [PubMed]
-
Maheswaran, S.; Haber, D.A. Circulating tumor cells: A window into cancer biology and metastasis. Curr. Opin. Genet. Dev. 2010, 20, 96–99. [CrossRef] [PubMed]
-
(2010)
Curr. Opin. Genet. Dev
, vol.20
, pp. 96-99
-
-
Maheswaran, S.1
Haber, D.A.2
-
16
-
-
0027267037
-
Molecular basis of tumor progression: Mechanisms of organ-specific tumor metastasis
-
[PubMed]
-
Yeatman, T.J.; Nicolson, G.L. Molecular basis of tumor progression: Mechanisms of organ-specific tumor metastasis. Semin. Surg. Oncol. 1993, 9, 256–263. [PubMed]
-
(1993)
Semin. Surg. Oncol
, vol.9
, pp. 256-263
-
-
Yeatman, T.J.1
Nicolson, G.L.2
-
17
-
-
33244463813
-
Complex networks orchestrate epithelial-mesenchymal transitions
-
[CrossRef] [PubMed]
-
Thiery, J.P.; Sleeman, J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7, 131–142. [CrossRef] [PubMed]
-
(2006)
Nat. Rev. Mol. Cell Biol
, vol.7
, pp. 131-142
-
-
Thiery, J.P.1
Sleeman, J.P.2
-
18
-
-
72249093615
-
Tumor self-seeding by circulating cancer cells
-
[CrossRef] [PubMed]
-
Kim, M.Y.; Oskarsson, T.; Acharyya, S.; Nguyen, D.X.; Zhang, X.H.; Norton, L.; Massague, J. Tumor self-seeding by circulating cancer cells. Cell 2009, 139, 1315–1326. [CrossRef] [PubMed]
-
(2009)
Cell
, vol.139
, pp. 1315-1326
-
-
Kim, M.Y.1
Oskarsson, T.2
Acharyya, S.3
Nguyen, D.X.4
Zhang, X.H.5
Norton, L.6
Massague, J.7
-
19
-
-
84856088337
-
EMT and dissemination precede pancreatic tumor formation
-
[CrossRef] [PubMed]
-
Rhim, A.D.; Mirek, E.T.; Aiello, N.M.; Maitra, A.; Bailey, J.M.; McAllister, F.; Reichert, M.; Beatty, G.L.; Rustgi, A.K.; Vonderheide, R.H. et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012, 148, 349–361. [CrossRef] [PubMed]
-
(2012)
Cell
, vol.148
, pp. 349-361
-
-
Rhim, A.D.1
Mirek, E.T.2
Aiello, N.M.3
Maitra, A.4
Bailey, J.M.5
McAllister, F.6
Reichert, M.7
Beatty, G.L.8
Rustgi, A.K.9
Vonderheide, R.H.10
-
20
-
-
84894314470
-
Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions
-
[CrossRef] [PubMed]
-
Rhim, A.D.; Thege, F.I.; Santana, S.M.; Lannin, T.B.; Saha, T.N.; Tsai, S.; Maggs, L.R.; Kochman, M.L.; Ginsberg, G.G.; Lieb, J.G. et al. Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions. Gastroenterology 2014, 146, 647–651. [CrossRef] [PubMed]
-
(2014)
Gastroenterology
, vol.146
, pp. 647-651
-
-
Rhim, A.D.1
Thege, F.I.2
Santana, S.M.3
Lannin, T.B.4
Saha, T.N.5
Tsai, S.6
Maggs, L.R.7
Kochman, M.L.8
Ginsberg, G.G.9
Lieb, J.G.10
-
21
-
-
84910008796
-
Sentinel circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease
-
[CrossRef] [PubMed]
-
Ilie, M.; Hofman, V.; Long-Mira, E.; Selva, E.; Vignaud, J.M.; Padovani, B.; Mouroux, J.; Marquette, C.H.; Hofman, P. “Sentinel” circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease. PLoS ONE 2014, 9, e111597. [CrossRef] [PubMed]
-
(2014)
Plos ONE
, vol.9
-
-
Ilie, M.1
Hofman, V.2
Long-Mira, E.3
Selva, E.4
Vignaud, J.M.5
Padovani, B.6
Mouroux, J.7
Marquette, C.H.8
Hofman, P.9
-
22
-
-
84879693078
-
Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer
-
[CrossRef] [PubMed]
-
Lianidou, E.S.; Mavroudis, D.; Georgoulias, V. Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer. Br. J. Cancer 2013, 108, 2426–2432. [CrossRef] [PubMed]
-
(2013)
Br. J. Cancer
, vol.108
, pp. 2426-2432
-
-
Lianidou, E.S.1
Mavroudis, D.2
Georgoulias, V.3
-
23
-
-
79952770095
-
Circulating tumour cells: Their utility in cancer management and predicting outcomes
-
[CrossRef] [PubMed]
-
Krebs, M.G.; Hou, J.M.; Ward, T.H.; Blackhall, F.H.; Dive, C. Circulating tumour cells: Their utility in cancer management and predicting outcomes. Ther. Adv. Med. Oncol. 2010, 2, 351–365. [CrossRef] [PubMed]
-
(2010)
Ther. Adv. Med. Oncol
, vol.2
, pp. 351-365
-
-
Krebs, M.G.1
Hou, J.M.2
Ward, T.H.3
Blackhall, F.H.4
Dive, C.5
-
24
-
-
77954624770
-
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer
-
[CrossRef] [PubMed]
-
Miller, M.C.; Doyle, G.V.; Terstappen, L.W.: Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer. J. Oncol. 2010, 2010, 617421. [CrossRef] [PubMed]
-
(2010)
J. Oncol
, vol.2010
-
-
Miller, M.C.1
Doyle, G.V.2
Terstappen, L.W.3
-
25
-
-
49249130844
-
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
-
[CrossRef] [PubMed]
-
Cohen, S.J.; Punt, C.J.; Iannotti, N.; Saidman, B.H.; Sabbath, K.D.; Gabrail, N.Y.; Picus, J.; Morse, M.; Mitchell, E.; Miller, M.C. et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J. Clin. Oncol. 2008, 26, 3213–3221. [CrossRef] [PubMed]
-
(2008)
J. Clin. Oncol
, vol.26
, pp. 3213-3221
-
-
Cohen, S.J.1
Punt, C.J.2
Iannotti, N.3
Saidman, B.H.4
Sabbath, K.D.5
Gabrail, N.Y.6
Picus, J.7
Morse, M.8
Mitchell, E.9
Miller, M.C.10
-
26
-
-
58149165081
-
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer
-
[CrossRef] [PubMed]
-
De Bono, J.S.; Scher, H.I.; Montgomery, R.B.; Parker, C.; Miller, M.C.; Tissing, H.; Doyle, G.V.; Terstappen, L.W.; Pienta, K.J.; Raghavan, D. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res. 2008, 14, 6302–6309. [CrossRef] [PubMed]
-
(2008)
Clin. Cancer Res
, vol.14
, pp. 6302-6309
-
-
De Bono, J.S.1
Scher, H.I.2
Montgomery, R.B.3
Parker, C.4
Miller, M.C.5
Tissing, H.6
Doyle, G.V.7
Terstappen, L.W.8
Pienta, K.J.9
Raghavan, D.10
-
27
-
-
33847402612
-
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the CellSearch system
-
[CrossRef] [PubMed]
-
Riethdorf, S.; Fritsche, H.; Muller, V.; Rau, T.; Schindlbeck, C.; Rack, B.; Janni, W.; Coith, C.; Beck, K.; Janicke, F. et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the CellSearch system. Clin. Cancer Res. 2007, 13, 920–928. [CrossRef] [PubMed]
-
(2007)
Clin. Cancer Res
, vol.13
, pp. 920-928
-
-
Riethdorf, S.1
Fritsche, H.2
Muller, V.3
Rau, T.4
Schindlbeck, C.5
Rack, B.6
Janni, W.7
Coith, C.8
Beck, K.9
Janicke, F.10
-
28
-
-
84867556074
-
Meta-analysis of the prognostic value of circulating tumor cells in breast cancer
-
[CrossRef] [PubMed]
-
Zhang, L.; Riethdorf, S.; Wu, G.; Wang, T.; Yang, K.; Peng, G.; Liu, J.; Pantel, K. Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin. Cancer Res. 2012, 18, 5701–5710. [CrossRef] [PubMed]
-
(2012)
Clin. Cancer Res
, vol.18
, pp. 5701-5710
-
-
Zhang, L.1
Riethdorf, S.2
Wu, G.3
Wang, T.4
Yang, K.5
Peng, G.6
Liu, J.7
Pantel, K.8
-
29
-
-
84897445481
-
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: A pooled analysis of individual patient data
-
[CrossRef]
-
Bidard, F.C.; Peeters, D.J.; Fehm, T.; Nole, F.; Gisbert-Criado, R.; Mavroudis, D.; Grisanti, S.; Generali, D.; Garcia-Saenz, J.A.; Stebbing, J. et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: A pooled analysis of individual patient data. Lancet Oncol. 2014, 15, 406–414. [CrossRef]
-
(2014)
Lancet Oncol
, vol.15
, pp. 406-414
-
-
Bidard, F.C.1
Peeters, D.J.2
Fehm, T.3
Nole, F.4
Gisbert-Criado, R.5
Mavroudis, D.6
Grisanti, S.7
Generali, D.8
Garcia-Saenz, J.A.9
Stebbing, J.10
-
30
-
-
84954388317
-
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: Concept of the DETECT study program
-
[CrossRef] [PubMed]
-
Schramm, A.; Friedl, T.W.; Schochter, F.; Scholz, C.; de Gregorio, N.; Huober, J.; Rack, B.; Trapp, E.; Alunni-Fabbroni, M.; Muller, V. et al. Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: Concept of the DETECT study program. Arch. Gynecol. Obstet. 2016, 293, 271–281. [CrossRef] [PubMed]
-
(2016)
Arch. Gynecol. Obstet
, vol.293
, pp. 271-281
-
-
Schramm, A.1
Friedl, T.W.2
Schochter, F.3
Scholz, C.4
De Gregorio, N.5
Huober, J.6
Rack, B.7
Trapp, E.8
Alunni-Fabbroni, M.9
Muller, V.10
-
31
-
-
84903289929
-
Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S 0500
-
[CrossRef] [PubMed]
-
Smerage, J.B.; Barlow, W.E.; Hortobagyi, G.N.; Winer, E.P.; Leyland-Jones, B.; Srkalovic, G.; Tejwani, S.; Schott, A.F.; O’Rourke, M.A.; Lew, D.L. et al. Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S 0500. J. Clin. Oncol. 2014, 32, 3483–3489. [CrossRef] [PubMed]
-
(2014)
J. Clin. Oncol
, vol.32
, pp. 3483-3489
-
-
Smerage, J.B.1
Barlow, W.E.2
Hortobagyi, G.N.3
Winer, E.P.4
Leyland-Jones, B.5
Srkalovic, G.6
Tejwani, S.7
Schott, A.F.8
O’Rourke, M.A.9
Lew, D.L.10
-
32
-
-
84878112286
-
Clinical application of circulating tumor cells in breast cancer: Overview of the current interventional trials
-
[CrossRef] [PubMed]
-
Bidard, F.C.; Fehm, T.; Ignatiadis, M.; Smerage, J.B.; Alix-Panabieres, C.; Janni, W.; Messina, C.; Paoletti, C.; Muller, V.; Hayes, D.F. et al. Clinical application of circulating tumor cells in breast cancer: Overview of the current interventional trials. Cancer Metastasis Rev. 2013, 32, 179–188. [CrossRef] [PubMed]
-
(2013)
Cancer Metastasis Rev
, vol.32
, pp. 179-188
-
-
Bidard, F.C.1
Fehm, T.2
Ignatiadis, M.3
Smerage, J.B.4
Alix-Panabieres, C.5
Janni, W.6
Messina, C.7
Paoletti, C.8
Muller, V.9
Hayes, D.F.10
-
33
-
-
33846814619
-
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
-
[CrossRef] [PubMed]
-
Hayes, D.F.; Cristofanilli, M.; Budd, G.T.; Ellis, M.J.; Stopeck, A.; Miller, M.C.; Matera, J.; Allard, W.J.; Doyle, G.V.; Terstappen, L.W. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin. Cancer Res. 2006, 12, 4218–4224. [CrossRef] [PubMed]
-
(2006)
Clin. Cancer Res
, vol.12
, pp. 4218-4224
-
-
Hayes, D.F.1
Cristofanilli, M.2
Budd, G.T.3
Ellis, M.J.4
Stopeck, A.5
Miller, M.C.6
Matera, J.7
Allard, W.J.8
Doyle, G.V.9
Terstappen, L.W.10
-
34
-
-
84863105627
-
Circulating tumour cells in non-metastatic breast cancer: A prospective study
-
[CrossRef]
-
Lucci, A.; Hall, C.S.; Lodhi, A.K.; Bhattacharyya, A.; Anderson, A.E.; Xiao, L.; Bedrosian, I.; Kuerer, H.M.; Krishnamurthy, S. Circulating tumour cells in non-metastatic breast cancer: A prospective study. Lancet Oncol. 2012, 13, 688–695. [CrossRef]
-
(2012)
Lancet Oncol.
, vol.13
, pp. 688-695
-
-
Lucci, A.1
Hall, C.S.2
Lodhi, A.K.3
Bhattacharyya, A.4
Anderson, A.E.5
Xiao, L.6
Bedrosian, I.7
Kuerer, H.M.8
Krishnamurthy, S.9
-
35
-
-
84857613654
-
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients
-
[CrossRef] [PubMed]
-
Pierga, J.Y.; Hajage, D.; Bachelot, T.; Delaloge, S.; Brain, E.; Campone, M.; Dieras, V.; Rolland, E.; Mignot, L.; Mathiot, C. et al. High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients. Ann. Oncol. 2012, 23, 618–624. [CrossRef] [PubMed]
-
(2012)
Ann. Oncol
, vol.23
, pp. 618-624
-
-
Pierga, J.Y.1
Hajage, D.2
Bachelot, T.3
Delaloge, S.4
Brain, E.5
Campone, M.6
Dieras, V.7
Rolland, E.8
Mignot, L.9
Mathiot, C.10
-
36
-
-
78049485312
-
M30 neoepitope expression in epithelial cancer: Quantification of apoptosis in circulating tumor cells by CellSearch analysis
-
[CrossRef] [PubMed]
-
Rossi, E.; Basso, U.; Celadin, R.; Zilio, F.; Pucciarelli, S.; Aieta, M.; Barile, C.; Sava, T.; Bonciarelli, G.; Tumolo, S. et al. M30 neoepitope expression in epithelial cancer: Quantification of apoptosis in circulating tumor cells by CellSearch analysis. Clin. Cancer Res. 2010, 16, 5233–5243. [CrossRef] [PubMed]
-
(2010)
Clin. Cancer Res
, vol.16
, pp. 5233-5243
-
-
Rossi, E.1
Basso, U.2
Celadin, R.3
Zilio, F.4
Pucciarelli, S.5
Aieta, M.6
Barile, C.7
Sava, T.8
Bonciarelli, G.9
Tumolo, S.10
-
37
-
-
79251548904
-
HER2-positive circulating tumor cells in breast cancer
-
[CrossRef] [PubMed]
-
Ignatiadis, M.; Rothe, F.; Chaboteaux, C.; Durbecq, V.; Rouas, G.; Criscitiello, C.; Metallo, J.; Kheddoumi, N.; Singhal, S.K.; Michiels, S. et al. HER2-positive circulating tumor cells in breast cancer. PLoS ONE 2011, 6, e15624. [CrossRef] [PubMed]
-
(2011)
Plos ONE
, vol.6
-
-
Ignatiadis, M.1
Rothe, F.2
Chaboteaux, C.3
Durbecq, V.4
Rouas, G.5
Criscitiello, C.6
Metallo, J.7
Kheddoumi, N.8
Singhal, S.K.9
Michiels, S.10
-
38
-
-
84975763760
-
Tumor heterogeneity and circulating tumor cells
-
[CrossRef] [PubMed]
-
Zhang, C.; Guan, Y.; Sun, Y.; Ai, D.; Guo, Q. Tumor heterogeneity and circulating tumor cells. Cancer Lett. 2016, 374, 216–223. [CrossRef] [PubMed]
-
(2016)
Cancer Lett
, vol.374
, pp. 216-223
-
-
Zhang, C.1
Guan, Y.2
Sun, Y.3
Ai, D.4
Guo, Q.5
-
39
-
-
84862840385
-
Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer
-
[CrossRef] [PubMed]
-
Hayashi, N.; Nakamura, S.; Tokuda, Y.; Shimoda, Y.; Yagata, H.; Yoshida, A.; Ota, H.; Hortobagyi, G.N.; Cristofanilli, M.; Ueno, N.T. Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer. Int. J. Clin. Oncol. 2012, 17, 96–104. [CrossRef] [PubMed]
-
(2012)
Int. J. Clin. Oncol
, vol.17
, pp. 96-104
-
-
Hayashi, N.1
Nakamura, S.2
Tokuda, Y.3
Shimoda, Y.4
Yagata, H.5
Yoshida, A.6
Ota, H.7
Hortobagyi, G.N.8
Cristofanilli, M.9
Ueno, N.T.10
-
40
-
-
70449561613
-
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
-
[CrossRef] [PubMed]
-
Pestrin, M.; Bessi, S.; Galardi, F.; Truglia, M.; Biggeri, A.; Biagioni, C.; Cappadona, S.; Biganzoli, L.; Giannini, A.; Di Leo, A. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients. Breast Cancer Res. Treat. 2009, 118, 523–530. [CrossRef] [PubMed]
-
(2009)
Breast Cancer Res. Treat
, vol.118
, pp. 523-530
-
-
Pestrin, M.1
Bessi, S.2
Galardi, F.3
Truglia, M.4
Biggeri, A.5
Biagioni, C.6
Cappadona, S.7
Biganzoli, L.8
Giannini, A.9
Di Leo, A.10
-
41
-
-
78649327274
-
HER2 status of circulating tumor cells in patients with metastatic breast cancer: A prospective, multicenter trial
-
[CrossRef] [PubMed]
-
Fehm, T.; Muller, V.; Aktas, B.; Janni, W.; Schneeweiss, A.; Stickeler, E.; Lattrich, C.; Lohberg, C.R.; Solomayer, E.; Rack, B. et al. HER2 status of circulating tumor cells in patients with metastatic breast cancer: A prospective, multicenter trial. Breast Cancer Res. Treat. 2010, 124, 403–412. [CrossRef] [PubMed]
-
(2010)
Breast Cancer Res. Treat
, vol.124
, pp. 403-412
-
-
Fehm, T.1
Muller, V.2
Aktas, B.3
Janni, W.4
Schneeweiss, A.5
Stickeler, E.6
Lattrich, C.7
Lohberg, C.R.8
Solomayer, E.9
Rack, B.10
-
42
-
-
75449106680
-
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
-
[CrossRef] [PubMed]
-
Aktas, B.; Tewes, M.; Fehm, T.; Hauch, S.; Kimmig, R.; Kasimir-Bauer, S. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res. 2009, 11, R46. [CrossRef] [PubMed]
-
(2009)
Breast Cancer Res
, vol.11
, pp. 46
-
-
Aktas, B.1
Tewes, M.2
Fehm, T.3
Hauch, S.4
Kimmig, R.5
Kasimir-Bauer, S.6
-
43
-
-
67349253810
-
Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: An option for monitoring response to breast cancer related therapies
-
[CrossRef] [PubMed]
-
Tewes, M.; Aktas, B.; Welt, A.; Mueller, S.; Hauch, S.; Kimmig, R.; Kasimir-Bauer, S.: Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: An option for monitoring response to breast cancer related therapies. Breast Cancer Res. Treat. 2009, 115, 581–590. [CrossRef] [PubMed]
-
(2009)
Breast Cancer Res. Treat
, vol.115
, pp. 581-590
-
-
Tewes, M.1
Aktas, B.2
Welt, A.3
Mueller, S.4
Hauch, S.5
Kimmig, R.6
Kasimir-Bauer, S.7
-
44
-
-
84908084150
-
TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
-
[CrossRef] [PubMed]
-
Fernandez, S.V.; Bingham, C.; Fittipaldi, P.; Austin, L.; Palazzo, J.; Palmer, G.; Alpaugh, K.; Cristofanilli, M. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients. Breast Cancer Res. 2014, 16, 445. [CrossRef] [PubMed]
-
(2014)
Breast Cancer Res
, vol.16
, pp. 445
-
-
Fernandez, S.V.1
Bingham, C.2
Fittipaldi, P.3
Austin, L.4
Palazzo, J.5
Palmer, G.6
Alpaugh, K.7
Cristofanilli, M.8
-
45
-
-
84967154673
-
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer
-
[PubMed]
-
De Luca, F.; Rotunno, G.; Salvianti, F.; Galardi, F.; Pestrin, M.; Gabellini, S.; Simi, L.; Mancini, I.; Vannucchi, A.M.; Pazzagli, M. et al. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer. Oncotarget 2016, 7, 26107–26119. [PubMed]
-
(2016)
Oncotarget
, vol.7
, pp. 26107-26119
-
-
De Luca, F.1
Rotunno, G.2
Salvianti, F.3
Galardi, F.4
Pestrin, M.5
Gabellini, S.6
Simi, L.7
Mancini, I.8
Vannucchi, A.M.9
Pazzagli, M.10
-
46
-
-
84960090910
-
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis
-
[CrossRef] [PubMed]
-
Bulfoni, M.; Gerratana, L.; Del Ben, F.; Marzinotto, S.; Sorrentino, M.; Turetta, M.; Scoles, G.; Toffoletto, B.; Isola, M.; Beltrami, C.A. et al. In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis. Breast Cancer Res. 2016, 18, 30. [CrossRef] [PubMed]
-
(2016)
Breast Cancer Res
, vol.18
, pp. 30
-
-
Bulfoni, M.1
Gerratana, L.2
Del Ben, F.3
Marzinotto, S.4
Sorrentino, M.5
Turetta, M.6
Scoles, G.7
Toffoletto, B.8
Isola, M.9
Beltrami, C.A.10
-
47
-
-
84926419351
-
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
-
[CrossRef] [PubMed]
-
Pestrin, M.; Salvianti, F.; Galardi, F.; de Luca, F.; Turner, N.; Malorni, L.; Pazzagli, M.; di Leo, A.; Pinzani, P. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients. Mol. Oncol. 2015, 9, 749–757. [CrossRef] [PubMed]
-
(2015)
Mol. Oncol
, vol.9
, pp. 749-757
-
-
Pestrin, M.1
Salvianti, F.2
Galardi, F.3
De Luca, F.4
Turner, N.5
Malorni, L.6
Pazzagli, M.7
Di Leo, A.8
Pinzani, P.9
-
48
-
-
84910671460
-
Molecular profiling of single circulating tumor cells with diagnostic intention
-
[CrossRef] [PubMed]
-
Polzer, B.; Medoro, G.; Pasch, S.; Fontana, F.; Zorzino, L.; Pestka, A.; Andergassen, U.; Meier-Stiegen, F.; Czyz, Z.T.; Alberter, B. et al. Molecular profiling of single circulating tumor cells with diagnostic intention. EMBO Mol. Med. 2014, 6, 1371–1386. [CrossRef] [PubMed]
-
(2014)
EMBO Mol. Med
, vol.6
, pp. 1371-1386
-
-
Polzer, B.1
Medoro, G.2
Pasch, S.3
Fontana, F.4
Zorzino, L.5
Pestka, A.6
Andergassen, U.7
Meier-Stiegen, F.8
Czyz, Z.T.9
Alberter, B.10
-
49
-
-
3042552362
-
HER-2 gene amplification can be acquired as breast cancer progresses
-
[CrossRef] [PubMed]
-
Meng, S.; Tripathy, D.; Shete, S.; Ashfaq, R.; Haley, B.; Perkins, S.; Beitsch, P.; Khan, A.; Euhus, D.; Osborne, C. et al. HER-2 gene amplification can be acquired as breast cancer progresses. Proc. Natl. Acad. Sci. USA 2004, 101, 9393–9398. [CrossRef] [PubMed]
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 9393-9398
-
-
Meng, S.1
Tripathy, D.2
Shete, S.3
Ashfaq, R.4
Haley, B.5
Perkins, S.6
Beitsch, P.7
Khan, A.8
Euhus, D.9
Osborne, C.10
-
50
-
-
84873811988
-
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition
-
[CrossRef] [PubMed]
-
Yu, M.; Bardia, A.; Wittner, B.S.; Stott, S.L.; Smas, M.E.; Ting, D.T.; Isakoff, S.J.; Ciciliano, J.C.; Wells, M.N.; Shah, A.M. et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013, 339, 580–584. [CrossRef] [PubMed]
-
(2013)
Science
, vol.339
, pp. 580-584
-
-
Yu, M.1
Bardia, A.2
Wittner, B.S.3
Stott, S.L.4
Smas, M.E.5
Ting, D.T.6
Isakoff, S.J.7
Ciciliano, J.C.8
Wells, M.N.9
Shah, A.M.10
-
51
-
-
84891809462
-
Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients
-
[CrossRef] [PubMed]
-
Ramirez, J.M.; Fehm, T.; Orsini, M.; Cayrefourcq, L.; Maudelonde, T.; Pantel, K.; Alix-Panabieres, C. Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients. Clin. Chem. 2014, 60, 214–221. [CrossRef] [PubMed]
-
(2014)
Clin. Chem
, vol.60
, pp. 214-221
-
-
Ramirez, J.M.1
Fehm, T.2
Orsini, M.3
Cayrefourcq, L.4
Maudelonde, T.5
Pantel, K.6
Alix-Panabieres, C.7
-
52
-
-
80052511419
-
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
-
[CrossRef] [PubMed]
-
Farace, F.; Massard, C.; Vimond, N.; Drusch, F.; Jacques, N.; Billiot, F.; Laplanche, A.; Chauchereau, A.; Lacroix, L.; Planchard, D. et al. A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br. J. Cancer 2011, 105, 847–853. [CrossRef] [PubMed]
-
(2011)
Br. J. Cancer
, vol.105
, pp. 847-853
-
-
Farace, F.1
Massard, C.2
Vimond, N.3
Drusch, F.4
Jacques, N.5
Billiot, F.6
Laplanche, A.7
Chauchereau, A.8
Lacroix, L.9
Planchard, D.10
-
53
-
-
0242525672
-
Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system
-
[PubMed]
-
Stathopoulou, A.; Gizi, A.; Perraki, M.; Apostolaki, S.; Malamos, N.; Mavroudis, D.; Georgoulias, V.; Lianidou, E.S. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system. Clin. Cancer Res. 2003, 9, 5145–5151. [PubMed]
-
(2003)
Clin. Cancer Res
, vol.9
, pp. 5145-5151
-
-
Stathopoulou, A.1
Gizi, A.2
Perraki, M.3
Apostolaki, S.4
Malamos, N.5
Mavroudis, D.6
Georgoulias, V.7
Lianidou, E.S.8
-
54
-
-
84869231518
-
Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer
-
[CrossRef] [PubMed]
-
Giordano, A.; Gao, H.; Anfossi, S.; Cohen, E.; Mego, M.; Lee, B.N.; Tin, S.; De Laurentiis, M.; Parker, C.A.; Alvarez, R.H. et al. Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer. Mol. Cancer Ther. 2012, 11, 2526–2534. [CrossRef] [PubMed]
-
(2012)
Mol. Cancer Ther
, vol.11
, pp. 2526-2534
-
-
Giordano, A.1
Gao, H.2
Anfossi, S.3
Cohen, E.4
Mego, M.5
Lee, B.N.6
Tin, S.7
De Laurentiis, M.8
Parker, C.A.9
Alvarez, R.H.10
-
55
-
-
84861712713
-
Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis
-
[CrossRef] [PubMed]
-
Barriere, G.; Riouallon, A.; Renaudie, J.; Tartary, M.; Rigaud, M. Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis. BMC Cancer 2012, 12, 114. [CrossRef] [PubMed]
-
(2012)
BMC Cancer
, vol.12
, pp. 114
-
-
Barriere, G.1
Riouallon, A.2
Renaudie, J.3
Tartary, M.4
Rigaud, M.5
-
56
-
-
0036595629
-
Epithelial-mesenchymal transitions in tumour progression
-
[CrossRef] [PubMed]
-
Thiery, J.P.: Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2, 442–454. [CrossRef] [PubMed]
-
(2002)
Nat. Rev. Cancer
, vol.2
, pp. 442-454
-
-
Thiery, J.P.1
-
57
-
-
84901814702
-
Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients
-
[CrossRef] [PubMed]
-
Krawczyk, N.; Meier-Stiegen, F.; Banys, M.; Neubauer, H.; Ruckhaeberle, E.; Fehm, T. Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients. BioMed Res. Int. 2014, 2014, 415721. [CrossRef] [PubMed]
-
(2014)
Biomed Res. Int
, vol.2014
-
-
Krawczyk, N.1
Meier-Stiegen, F.2
Banys, M.3
Neubauer, H.4
Ruckhaeberle, E.5
Fehm, T.6
-
58
-
-
84860389952
-
Epithelial-mesenchymal transition and cancer stem cells: A dangerously dynamic duo in breast cancer progression
-
[CrossRef] [PubMed]
-
May, C.D.; Sphyris, N.; Evans, K.W.; Werden, S.J.; Guo, W.; Mani, S.A.: Epithelial-mesenchymal transition and cancer stem cells: A dangerously dynamic duo in breast cancer progression. Breast Cancer Res. 2011, 13, 202. [CrossRef] [PubMed]
-
(2011)
Breast Cancer Res
, vol.13
, pp. 202
-
-
May, C.D.1
Sphyris, N.2
Evans, K.W.3
Werden, S.J.4
Guo, W.5
Mani, S.A.6
-
59
-
-
82955187028
-
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
-
[CrossRef] [PubMed]
-
Raimondi, C.; Gradilone, A.; Naso, G.; Vincenzi, B.; Petracca, A.; Nicolazzo, C.; Palazzo, A.; Saltarelli, R.; Spremberg, F.; Cortesi, E. et al. Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Res. Treat. 2011, 130, 449–455. [CrossRef] [PubMed]
-
(2011)
Breast Cancer Res. Treat
, vol.130
, pp. 449-455
-
-
Raimondi, C.1
Gradilone, A.2
Naso, G.3
Vincenzi, B.4
Petracca, A.5
Nicolazzo, C.6
Palazzo, A.7
Saltarelli, R.8
Spremberg, F.9
Cortesi, E.10
-
60
-
-
84860999602
-
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
-
[CrossRef] [PubMed]
-
Gorges, T.M.; Tinhofer, I.; Drosch, M.; Rose, L.; Zollner, T.M.; Krahn, T.; von Ahsen, O. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer 2012, 12, 178. [CrossRef] [PubMed]
-
(2012)
BMC Cancer
, vol.12
, pp. 178
-
-
Gorges, T.M.1
Tinhofer, I.2
Drosch, M.3
Rose, L.4
Zollner, T.M.5
Krahn, T.6
Von Ahsen, O.7
-
61
-
-
84899491673
-
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients
-
[CrossRef] [PubMed]
-
Lustberg, M.B.; Balasubramanian, P.; Miller, B.; Garcia-Villa, A.; Deighan, C.; Wu, Y.; Carothers, S.; Berger, M.; Ramaswamy, B.; Macrae, E.R. et al. Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients. Breast Cancer Res. 2014, 16, R23. [CrossRef] [PubMed]
-
(2014)
Breast Cancer Res
, vol.16
-
-
Lustberg, M.B.1
Balasubramanian, P.2
Miller, B.3
Garcia-Villa, A.4
Deighan, C.5
Wu, Y.6
Carothers, S.7
Berger, M.8
Ramaswamy, B.9
Macrae, E.R.10
-
62
-
-
58549113573
-
Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells
-
[CrossRef] [PubMed]
-
Sieuwerts, A.M.; Kraan, J.; Bolt, J.; van der Spoel, P.; Elstrodt, F.; Schutte, M.; Martens, J.W.; Gratama, J.W.; Sleijfer, S.; Foekens, J.A.: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J. Natl. Cancer Inst. 2009, 101, 61–66. [CrossRef] [PubMed]
-
(2009)
J. Natl. Cancer Inst
, vol.101
, pp. 61-66
-
-
Sieuwerts, A.M.1
Kraan, J.2
Bolt, J.3
Van Der Spoel, P.4
Elstrodt, F.5
Schutte, M.6
Martens, J.W.7
Gratama, J.W.8
Sleijfer, S.9
Foekens, J.A.10
-
63
-
-
47549102418
-
Epithelial mesenchymal transition traits in human breast cancer cell lines
-
[CrossRef] [PubMed]
-
Blick, T.; Widodo, E.; Hugo, H.; Waltham, M.; Lenburg, M.E.; Neve, R.M.; Thompson, E.W. Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin. Exp. Metastasis 2008, 25, 629–642. [CrossRef] [PubMed]
-
(2008)
Clin. Exp. Metastasis
, vol.25
, pp. 629-642
-
-
Blick, T.1
Widodo, E.2
Hugo, H.3
Waltham, M.4
Lenburg, M.E.5
Neve, R.M.6
Thompson, E.W.7
-
64
-
-
84959119689
-
Circulating tumor cell technologies
-
[CrossRef] [PubMed]
-
Ferreira, M.M.; Ramani, V.C.; Jeffrey, S.S. Circulating tumor cell technologies. Mol. Oncol. 2016, 10, 374–394. [CrossRef] [PubMed]
-
(2016)
Mol. Oncol
, vol.10
, pp. 374-394
-
-
Ferreira, M.M.1
Ramani, V.C.2
Jeffrey, S.S.3
-
65
-
-
84959093230
-
Functional studies on circulating and disseminated tumor cells in carcinoma patients
-
[CrossRef] [PubMed]
-
Alix-Panabieres, C.; Bartkowiak, K.; Pantel, K. Functional studies on circulating and disseminated tumor cells in carcinoma patients. Mol. Oncol. 2016, 10, 443–449. [CrossRef] [PubMed]
-
(2016)
Mol. Oncol
, vol.10
, pp. 443-449
-
-
Alix-Panabieres, C.1
Bartkowiak, K.2
Pantel, K.3
-
66
-
-
83755196341
-
Circulating tumors cells as biomarkers: Progress toward biomarker qualification
-
[CrossRef] [PubMed]
-
Danila, D.C.; Pantel, K.; Fleisher, M.; Scher, H.I. Circulating tumors cells as biomarkers: Progress toward biomarker qualification. Cancer J. 2011, 17, 438–450. [CrossRef] [PubMed]
-
(2011)
Cancer J
, vol.17
, pp. 438-450
-
-
Danila, D.C.1
Pantel, K.2
Fleisher, M.3
Scher, H.I.4
-
67
-
-
84940959297
-
Sub classification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases
-
[CrossRef] [PubMed]
-
Chen, J.F.; Ho, H.; Lichterman, J.; Lu, Y.T.; Zhang, Y.; Garcia, M.A.; Chen, S.F.; Liang, A.J.; Hodara, E.; Zhau, H.E. et al. Sub classification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases. Cancer 2015, 121, 3240–3251. [CrossRef] [PubMed]
-
(2015)
Cancer
, vol.121
, pp. 3240-3251
-
-
Chen, J.F.1
Ho, H.2
Lichterman, J.3
Lu, Y.T.4
Zhang, Y.5
Garcia, M.A.6
Chen, S.F.7
Liang, A.J.8
Hodara, E.9
Zhau, H.E.10
-
68
-
-
84988410145
-
Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer
-
[CrossRef] [PubMed]
-
McDaniel, A.S.; Ferraldeschi, R.; Krupa, R.; Landers, M.; Graf, R.; Louw, J.; Jendrisak, A.; Bales, N.; Marrinucci, D.; Zafeiriou, Z. et al. Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer. BJU Int. 2016. [CrossRef] [PubMed]
-
(2016)
BJU Int
-
-
McDaniel, A.S.1
Ferraldeschi, R.2
Krupa, R.3
Landers, M.4
Graf, R.5
Louw, J.6
Jendrisak, A.7
Bales, N.8
Marrinucci, D.9
Zafeiriou, Z.10
-
69
-
-
84907342688
-
Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis
-
[CrossRef] [PubMed]
-
Aceto, N.; Bardia, A.; Miyamoto, D.T.; Donaldson, M.C.; Wittner, B.S.; Spencer, J.A.; Yu, M.; Pely, A.; Engstrom, A.; Zhu, H. et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 2014, 158, 1110–1122. [CrossRef] [PubMed]
-
(2014)
Cell
, vol.158
, pp. 1110-1122
-
-
Aceto, N.1
Bardia, A.2
Miyamoto, D.T.3
Donaldson, M.C.4
Wittner, B.S.5
Spencer, J.A.6
Yu, M.7
Pely, A.8
Engstrom, A.9
Zhu, H.10
-
70
-
-
84934297821
-
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
-
[CrossRef] [PubMed]
-
Jolly, M.K.; Boareto, M.; Huang, B.; Jia, D.; Lu, M.; Ben-Jacob, E.; Onuchic, J.N.; Levine, H. Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis. Front. Oncol. 2015, 5, 155. [CrossRef] [PubMed]
-
(2015)
Front. Oncol
, vol.5
, pp. 155
-
-
Jolly, M.K.1
Boareto, M.2
Huang, B.3
Jia, D.4
Lu, M.5
Ben-Jacob, E.6
Onuchic, J.N.7
Levine, H.8
-
71
-
-
78649872067
-
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
-
[CrossRef] [PubMed]
-
Stott, S.L.; Hsu, C.H.; Tsukrov, D.I.; Yu, M.; Miyamoto, D.T.; Waltman, B.A.; Rothenberg, S.M.; Shah, A.M.; Smas, M.E.; Korir, G.K. et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl. Acad. Sci. USA 2010, 107, 18392–18397. [CrossRef] [PubMed]
-
(2010)
Proc. Natl. Acad. Sci. USA
, vol.107
, pp. 18392-18397
-
-
Stott, S.L.1
Hsu, C.H.2
Tsukrov, D.I.3
Yu, M.4
Miyamoto, D.T.5
Waltman, B.A.6
Rothenberg, S.M.7
Shah, A.M.8
Smas, M.E.9
Korir, G.K.10
-
72
-
-
84856948692
-
Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors
-
[CrossRef] [PubMed]
-
Cho, E.H.; Wendel, M.; Luttgen, M.; Yoshioka, C.; Marrinucci, D.; Lazar, D.; Schram, E.; Nieva, J.; Bazhenova, L.; Morgan, A. et al. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys. Biol. 2012, 9, 016001. [CrossRef] [PubMed]
-
(2012)
Phys. Biol
, vol.9
-
-
Cho, E.H.1
Wendel, M.2
Luttgen, M.3
Yoshioka, C.4
Marrinucci, D.5
Lazar, D.6
Schram, E.7
Nieva, J.8
Bazhenova, L.9
Morgan, A.10
-
73
-
-
84934437818
-
A microfluidic device for label-free, physical capture of circulating tumor cell clusters
-
[CrossRef] [PubMed]
-
Sarioglu, A.F.; Aceto, N.; Kojic, N.; Donaldson, M.C.; Zeinali, M.; Hamza, B.; Engstrom, A.; Zhu, H.; Sundaresan, T.K.; Miyamoto, D.T. et al. A microfluidic device for label-free, physical capture of circulating tumor cell clusters. Nat. Methods 2015, 12, 685–691. [CrossRef] [PubMed]
-
(2015)
Nat. Methods
, vol.12
, pp. 685-691
-
-
Sarioglu, A.F.1
Aceto, N.2
Kojic, N.3
Donaldson, M.C.4
Zeinali, M.5
Hamza, B.6
Engstrom, A.7
Zhu, H.8
Sundaresan, T.K.9
Miyamoto, D.T.10
-
74
-
-
84969204386
-
The potential for liquid biopsies in the precision medical treatment of breast cancer
-
[CrossRef] [PubMed]
-
Forte, V.A.; Barrak, D.K.; Elhodaky, M.; Tung, L.; Snow, A.; Lang, J.E. The potential for liquid biopsies in the precision medical treatment of breast cancer. Cancer Biol. Med. 2016, 13, 19–40. [CrossRef] [PubMed]
-
(2016)
Cancer Biol. Med
, vol.13
, pp. 19-40
-
-
Forte, V.A.1
Barrak, D.K.2
Elhodaky, M.3
Tung, L.4
Snow, A.5
Lang, J.E.6
-
75
-
-
84894593599
-
Molecular mechanisms of epithelial-mesenchymal transition
-
[CrossRef] [PubMed]
-
Lamouille, S.; Xu, J.; Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 2014, 15, 178–196. [CrossRef] [PubMed]
-
(2014)
Nat. Rev. Mol. Cell Biol
, vol.15
, pp. 178-196
-
-
Lamouille, S.1
Xu, J.2
Derynck, R.3
-
76
-
-
84855987633
-
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
-
[CrossRef] [PubMed]
-
Kasimir-Bauer, S.; Hoffmann, O.; Wallwiener, D.; Kimmig, R.; Fehm, T. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Res. 2012, 14, R15. [CrossRef] [PubMed]
-
(2012)
Breast Cancer Res
, vol.14
, pp. 15
-
-
Kasimir-Bauer, S.1
Hoffmann, O.2
Wallwiener, D.3
Kimmig, R.4
Fehm, T.5
-
77
-
-
84880329544
-
Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation
-
[CrossRef] [PubMed]
-
Mego, M.; Gao, H.; Lee, B.N.; Cohen, E.N.; Tin, S.; Giordano, A.; Wu, Q.; Liu, P.; Nieto, Y.; Champlin, R.E. et al. Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation. J. Cancer 2012, 3, 369–380. [CrossRef] [PubMed]
-
(2012)
J. Cancer
, vol.3
, pp. 369-380
-
-
Mego, M.1
Gao, H.2
Lee, B.N.3
Cohen, E.N.4
Tin, S.5
Giordano, A.6
Wu, Q.7
Liu, P.8
Nieto, Y.9
Champlin, R.E.10
-
78
-
-
79961118743
-
Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells
-
[CrossRef] [PubMed]
-
Mego, M.; De Giorgi, U.; Dawood, S.; Wang, X.; Valero, V.; Andreopoulou, E.; Handy, B.; Ueno, N.T.; Reuben, J.M.; Cristofanilli, M. Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells. Int. J. Cancer 2011, 129, 417–423. [CrossRef] [PubMed]
-
(2011)
Int. J. Cancer
, vol.129
, pp. 417-423
-
-
Mego, M.1
De Giorgi, U.2
Dawood, S.3
Wang, X.4
Valero, V.5
Andreopoulou, E.6
Handy, B.7
Ueno, N.T.8
Reuben, J.M.9
Cristofanilli, M.10
-
79
-
-
80051988763
-
Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers
-
[CrossRef] [PubMed]
-
Armstrong, A.J.; Marengo, M.S.; Oltean, S.; Kemeny, G.; Bitting, R.L.; Turnbull, J.D.; Herold, C.I.; Marcom, P.K.; George, D.J.; Garcia-Blanco, M.A. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol. Cancer Res. 2011, 9, 997–1007. [CrossRef] [PubMed]
-
(2011)
Mol. Cancer Res
, vol.9
, pp. 997-1007
-
-
Armstrong, A.J.1
Marengo, M.S.2
Oltean, S.3
Kemeny, G.4
Bitting, R.L.5
Turnbull, J.D.6
Herold, C.I.7
Marcom, P.K.8
George, D.J.9
Garcia-Blanco, M.A.10
-
80
-
-
84860397754
-
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
-
[CrossRef] [PubMed]
-
Kallergi, G.; Papadaki, M.A.; Politaki, E.; Mavroudis, D.; Georgoulias, V.; Agelaki, S. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. Breast Cancer Res. 2011, 13, R59. [CrossRef] [PubMed]
-
(2011)
Breast Cancer Res
, vol.13
, pp. 59
-
-
Kallergi, G.1
Papadaki, M.A.2
Politaki, E.3
Mavroudis, D.4
Georgoulias, V.5
Agelaki, S.6
-
81
-
-
84884512463
-
Apoptotic circulating tumor cells in early and metastatic breast cancer patients
-
[CrossRef] [PubMed]
-
Kallergi, G.; Konstantinidis, G.; Markomanolaki, H.; Papadaki, M.A.; Mavroudis, D.; Stournaras, C.; Georgoulias, V.; Agelaki, S. Apoptotic circulating tumor cells in early and metastatic breast cancer patients. Mol. Cancer Ther. 2013, 12, 1886–1895. [CrossRef] [PubMed]
-
(2013)
Mol. Cancer Ther
, vol.12
, pp. 1886-1895
-
-
Kallergi, G.1
Konstantinidis, G.2
Markomanolaki, H.3
Papadaki, M.A.4
Mavroudis, D.5
Stournaras, C.6
Georgoulias, V.7
Agelaki, S.8
-
82
-
-
0035499267
-
Stem cells, cancer, and cancer stem cells
-
[CrossRef] [PubMed]
-
Reya, T.; Morrison, S.J.; Clarke, M.F.; Weissman, I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414, 105–111. [CrossRef] [PubMed]
-
(2001)
Nature
, vol.414
, pp. 105-111
-
-
Reya, T.1
Morrison, S.J.2
Clarke, M.F.3
Weissman, I.L.4
-
83
-
-
73649125337
-
Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer
-
[CrossRef] [PubMed]
-
Theodoropoulos, P.A.; Polioudaki, H.; Agelaki, S.; Kallergi, G.; Saridaki, Z.; Mavroudis, D.; Georgoulias, V. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Lett. 2010, 288, 99–106. [CrossRef] [PubMed]
-
(2010)
Cancer Lett
, vol.288
, pp. 99-106
-
-
Theodoropoulos, P.A.1
Polioudaki, H.2
Agelaki, S.3
Kallergi, G.4
Saridaki, Z.5
Mavroudis, D.6
Georgoulias, V.7
-
84
-
-
43049165453
-
The epithelial-mesenchymal transition generates cells with properties of stem cells
-
[CrossRef] [PubMed]
-
Mani, S.A.; Guo, W.; Liao, M.J.; Eaton, E.N.; Ayyanan, A.; Zhou, A.Y.; Brooks, M.; Reinhard, F.; Zhang, C.C.; Shipitsin, M. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133, 704–715. [CrossRef] [PubMed]
-
(2008)
Cell
, vol.133
, pp. 704-715
-
-
Mani, S.A.1
Guo, W.2
Liao, M.J.3
Eaton, E.N.4
Ayyanan, A.5
Zhou, A.Y.6
Brooks, M.7
Reinhard, F.8
Zhang, C.C.9
Shipitsin, M.10
-
85
-
-
51449085561
-
Generation of breast cancer stem cells through epithelial-mesenchymal transition
-
[CrossRef] [PubMed]
-
Morel, A.P.; Lievre, M.; Thomas, C.; Hinkal, G.; Ansieau, S.; Puisieux, A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008, 3, e2888. [CrossRef] [PubMed]
-
(2008)
Plos ONE
, vol.3
-
-
Morel, A.P.1
Lievre, M.2
Thomas, C.3
Hinkal, G.4
Ansieau, S.5
Puisieux, A.6
-
86
-
-
84862799824
-
Effects of the combination of RAD001 and docetaxel on breast cancer stem cells
-
[CrossRef] [PubMed]
-
Zhang, X.; Zhang, S.; Liu, Y.; Liu, J.; Ma, Y.; Zhu, Y.; Zhang, J.: Effects of the combination of RAD001 and docetaxel on breast cancer stem cells. Eur. J. Cancer 2012, 48, 1581–1592. [CrossRef] [PubMed]
-
(2012)
Eur. J. Cancer
, vol.48
, pp. 1581-1592
-
-
Zhang, X.1
Zhang, S.2
Liu, Y.3
Liu, J.4
Ma, Y.5
Zhu, Y.6
Zhang, J.7
-
87
-
-
84864558874
-
Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: A GINECO study
-
[CrossRef] [PubMed]
-
Bachelot, T.; Bourgier, C.; Cropet, C.; Ray-Coquard, I.; Ferrero, J.M.; Freyer, G.; Abadie-Lacourtoisie, S.; Eymard, J.C.; Debled, M.; Spaeth, D. et al. Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: A GINECO study. J. Clin. Oncol. 2012, 30, 2718–2724. [CrossRef] [PubMed]
-
(2012)
J. Clin. Oncol
, vol.30
, pp. 2718-2724
-
-
Bachelot, T.1
Bourgier, C.2
Cropet, C.3
Ray-Coquard, I.4
Ferrero, J.M.5
Freyer, G.6
Abadie-Lacourtoisie, S.7
Eymard, J.C.8
Debled, M.9
Spaeth, D.10
-
88
-
-
84863078767
-
Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer
-
[CrossRef] [PubMed]
-
Baselga, J.; Campone, M.; Piccart, M.; Burris, H.A., III; Rugo, H.S.; Sahmoud, T.; Noguchi, S.; Gnant, M.; Pritchard, K.I.; Lebrun, F. et al. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N. Engl. J. Med. 2012, 366, 520–529. [CrossRef] [PubMed]
-
(2012)
N. Engl. J. Med.
, vol.366
, pp. 520-529
-
-
Baselga, J.1
Campone, M.2
Piccart, M.3
Burris, H.A.4
Rugo, H.S.5
Sahmoud, T.6
Noguchi, S.7
Gnant, M.8
Pritchard, K.I.9
Lebrun, F.10
-
89
-
-
84937523280
-
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): A phase 3, randomised, double-blind, multicentre trial
-
[CrossRef]
-
Hurvitz, S.A.; Andre, F.; Jiang, Z.; Shao, Z.; Mano, M.S.; Neciosup, S.P.; Tseng, L.M.; Zhang, Q.; Shen, K.; Liu, D. et al. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): A phase 3, randomised, double-blind, multicentre trial. Lancet Oncol. 2015, 16, 816–829. [CrossRef]
-
(2015)
Lancet Oncol
, vol.16
, pp. 816-829
-
-
Hurvitz, S.A.1
Andre, F.2
Jiang, Z.3
Shao, Z.4
Mano, M.S.5
Neciosup, S.P.6
Tseng, L.M.7
Zhang, Q.8
Shen, K.9
Liu, D.10
-
90
-
-
84899992665
-
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): A randomised, double-blind, placebo-controlled phase 3 trial
-
[CrossRef]
-
Andre, F.; O’Regan, R.; Ozguroglu, M.; Toi, M.; Xu, B.; Jerusalem, G.; Masuda, N.; Wilks, S.; Arena, F.; Isaacs, C. et al. Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet Oncol. 2014, 15, 580–591. [CrossRef]
-
(2014)
Lancet Oncol
, vol.15
, pp. 580-591
-
-
Andre, F.1
O’Regan, R.2
Ozguroglu, M.3
Toi, M.4
Xu, B.5
Jerusalem, G.6
Masuda, N.7
Wilks, S.8
Arena, F.9
Isaacs, C.10
-
91
-
-
85013106576
-
Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
-
[CrossRef] [PubMed]
-
Du, B.; Shim, J.S. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. Molecules 2016, 21, 7. [CrossRef] [PubMed]
-
(2016)
Molecules
, vol.21
, pp. 7
-
-
Du, B.1
Shim, J.S.2
-
92
-
-
84874857331
-
HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: Implications for efficacy of adjuvant trastuzumab
-
[CrossRef] [PubMed]
-
Ithimakin, S.; Day, K.C.; Malik, F.; Zen, Q.; Dawsey, S.J.; Bersano-Begey, T.F.; Quraishi, A.A.; Ignatoski, K.W.; Daignault, S.; Davis, A. et al. HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: Implications for efficacy of adjuvant trastuzumab. Cancer Res. 2013, 73, 1635–1646. [CrossRef] [PubMed]
-
(2013)
Cancer Res
, vol.73
, pp. 1635-1646
-
-
Ithimakin, S.1
Day, K.C.2
Malik, F.3
Zen, Q.4
Dawsey, S.J.5
Bersano-Begey, T.F.6
Quraishi, A.A.7
Ignatoski, K.W.8
Daignault, S.9
Davis, A.10
-
93
-
-
84865401715
-
Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population
-
[CrossRef] [PubMed]
-
Korkaya, H.; Kim, G.I.; Davis, A.; Malik, F.; Henry, N.L.; Ithimakin, S.; Quraishi, A.A.; Tawakkol, N.; D’Angelo, R.; Paulson, A.K. et al. Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. Mol. Cell. 2012, 47, 570–584. [CrossRef] [PubMed]
-
(2012)
Mol. Cell
, vol.47
, pp. 570-584
-
-
Korkaya, H.1
Kim, G.I.2
Davis, A.3
Malik, F.4
Henry, N.L.5
Ithimakin, S.6
Quraishi, A.A.7
Tawakkol, N.8
D’Angelo, R.9
Paulson, A.K.10
-
94
-
-
79952284127
-
Hallmarks of cancer: The next generation
-
[CrossRef] [PubMed]
-
Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646–674. [CrossRef] [PubMed]
-
(2011)
Cell
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
95
-
-
85006768050
-
The Metabolism of Tumors in the Body
-
[CrossRef] [PubMed]
-
Warburg, O.; Wind, F.; Negelein, E. The Metabolism of Tumors in the Body. J. Gen. Physiol. 1927, 8, 519–530. [CrossRef] [PubMed]
-
(1927)
J. Gen. Physiol
, vol.8
, pp. 519-530
-
-
Warburg, O.1
Wind, F.2
Negelein, E.3
-
96
-
-
84973125230
-
A Method for Detecting Circulating Tumor Cells Based on the Measurement of Single-Cell Metabolism in Droplet-Based Microfluidics
-
[CrossRef] [PubMed]
-
Del Ben, F.; Turetta, M.; Celetti, G.; Piruska, A.; Bulfoni, M.; Cesselli, D.; Huck, W.T.; Scoles, G.: A Method for Detecting Circulating Tumor Cells Based on the Measurement of Single-Cell Metabolism in Droplet-Based Microfluidics. Angew. Chem. Int. Ed. Engl. 2016, 55, 8581–8584. [CrossRef] [PubMed]
-
(2016)
Angew. Chem. Int. Ed. Engl
, vol.55
, pp. 8581-8584
-
-
Del Ben, F.1
Turetta, M.2
Celetti, G.3
Piruska, A.4
Bulfoni, M.5
Cesselli, D.6
Huck, W.T.7
Scoles, G.8
-
97
-
-
84931332727
-
Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: Not only from metastatic cancer of the breast but also of prostate cancer patients
-
[CrossRef] [PubMed]
-
Rossi, E.; Rugge, M.; Facchinetti, A.; Pizzi, M.; Nardo, G.; Barbieri, V.; Manicone, M.; De Faveri, S.; Chiara Scaini, M.; Basso, U. et al. Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: Not only from metastatic cancer of the breast but also of prostate cancer patients. Oncoscience 2014, 1, 49–56. [CrossRef] [PubMed]
-
(2014)
Oncoscience
, vol.1
, pp. 49-56
-
-
Rossi, E.1
Rugge, M.2
Facchinetti, A.3
Pizzi, M.4
Nardo, G.5
Barbieri, V.6
Manicone, M.7
De Faveri, S.8
Chiara Scaini, M.9
Basso, U.10
-
98
-
-
0035404539
-
Circulating breast cancer cells are frequently apoptotic
-
[CrossRef]
-
Mehes, G.; Witt, A.; Kubista, E.; Ambros, P.F. Circulating breast cancer cells are frequently apoptotic. Am. J. Pathol. 2001, 159, 17–20. [CrossRef]
-
(2001)
Am. J. Pathol
, vol.159
, pp. 17-20
-
-
Mehes, G.1
Witt, A.2
Kubista, E.3
Ambros, P.F.4
-
99
-
-
84867399103
-
Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer
-
[CrossRef] [PubMed]
-
Rossi, E.; Fassan, M.; Aieta, M.; Zilio, F.; Celadin, R.; Borin, M.; Grassi, A.; Troiani, L.; Basso, U.; Barile, C. et al. Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer. Br. J. Cancer 2012, 107, 1286–1294. [CrossRef] [PubMed]
-
(2012)
Br. J. Cancer
, vol.107
, pp. 1286-1294
-
-
Rossi, E.1
Fassan, M.2
Aieta, M.3
Zilio, F.4
Celadin, R.5
Borin, M.6
Grassi, A.7
Troiani, L.8
Basso, U.9
Barile, C.10
-
100
-
-
84979222160
-
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
-
DETECT Study Group, [CrossRef] [PubMed]
-
Aktas, B.; Kasimir-Bauer, S.; Muller, V.; Janni, W.; Fehm, T.; Wallwiener, D.; Pantel, K.; Tewes, M.; DETECT Study Group. Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients. BMC Cancer 2016, 16, 522. [CrossRef] [PubMed]
-
(2016)
BMC Cancer
, vol.16
, pp. 522
-
-
Aktas, B.1
Kasimir-Bauer, S.2
Muller, V.3
Janni, W.4
Fehm, T.5
Wallwiener, D.6
Pantel, K.7
Tewes, M.8
-
101
-
-
77951740458
-
Detection and HER2 expression of circulating tumor cells: Prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial
-
[CrossRef] [PubMed]
-
Riethdorf, S.; Muller, V.; Zhang, L.; Rau, T.; Loibl, S.; Komor, M.; Roller, M.; Huober, J.; Fehm, T.; Schrader, I. et al. Detection and HER2 expression of circulating tumor cells: Prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clin. Cancer Res. 2010, 16, 2634–2645. [CrossRef] [PubMed]
-
(2010)
Clin. Cancer Res
, vol.16
, pp. 2634-2645
-
-
Riethdorf, S.1
Muller, V.2
Zhang, L.3
Rau, T.4
Loibl, S.5
Komor, M.6
Roller, M.7
Huober, J.8
Fehm, T.9
Schrader, I.10
-
102
-
-
35148885729
-
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
-
[CrossRef] [PubMed]
-
Berns, K.; Horlings, H.M.; Hennessy, B.T.; Madiredjo, M.; Hijmans, E.M.; Beelen, K.; Linn, S.C.; Gonzalez-Angulo, A.M.; Stemke-Hale, K.; Hauptmann, M. et al. A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer. Cancer Cell. 2007, 12, 395–402. [CrossRef] [PubMed]
-
(2007)
Cancer Cell
, vol.12
, pp. 395-402
-
-
Berns, K.1
Horlings, H.M.2
Hennessy, B.T.3
Madiredjo, M.4
Hijmans, E.M.5
Beelen, K.6
Linn, S.C.7
Gonzalez-Angulo, A.M.8
Stemke-Hale, K.9
Hauptmann, M.10
-
103
-
-
56449111358
-
Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ 235
-
[CrossRef] [PubMed]
-
Eichhorn, P.J.; Gili, M.; Scaltriti, M.; Serra, V.; Guzman, M.; Nijkamp, W.; Beijersbergen, R.L.; Valero, V.; Seoane, J.; Bernards, R. et al. Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ 235. Cancer Res. 2008, 68, 9221–9230. [CrossRef] [PubMed]
-
(2008)
Cancer Res
, vol.68
, pp. 9221-9230
-
-
Eichhorn, P.J.1
Gili, M.2
Scaltriti, M.3
Serra, V.4
Guzman, M.5
Nijkamp, W.6
Beijersbergen, R.L.7
Valero, V.8
Seoane, J.9
Bernards, R.10
-
104
-
-
77951884331
-
Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines
-
[CrossRef] [PubMed]
-
Kataoka, Y.; Mukohara, T.; Shimada, H.; Saijo, N.; Hirai, M.; Minami, H.: Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines. Ann. Oncol. 2010, 21, 255–262. [CrossRef] [PubMed]
-
(2010)
Ann. Oncol
, vol.21
, pp. 255-262
-
-
Kataoka, Y.1
Mukohara, T.2
Shimada, H.3
Saijo, N.4
Hirai, M.5
Minami, H.6
-
105
-
-
79951834210
-
PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer
-
[CrossRef] [PubMed]
-
Dupont Jensen, J.; Laenkholm, A.V.; Knoop, A.; Ewertz, M.; Bandaru, R.; Liu, W.; Hackl, W.; Barrett, J.C.; Gardner, H.: PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer. Clin. Cancer Res. 2011, 17, 667–677. [CrossRef] [PubMed]
-
(2011)
Clin. Cancer Res
, vol.17
, pp. 667-677
-
-
Dupont Jensen, J.1
Laenkholm, A.V.2
Knoop, A.3
Ewertz, M.4
Bandaru, R.5
Liu, W.6
Hackl, W.7
Barrett, J.C.8
Gardner, H.9
-
106
-
-
84902705681
-
Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow
-
[CrossRef] [PubMed]
-
Deng, G.; Krishnakumar, S.; Powell, A.A.; Zhang, H.; Mindrinos, M.N.; Telli, M.L.; Davis, R.W.; Jeffrey, S.S. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow. BMC Cancer 2014, 14, 456. [CrossRef] [PubMed]
-
(2014)
BMC Cancer
, vol.14
, pp. 456
-
-
Deng, G.1
Krishnakumar, S.2
Powell, A.A.3
Zhang, H.4
Mindrinos, M.N.5
Telli, M.L.6
Davis, R.W.7
Jeffrey, S.S.8
-
107
-
-
84992718335
-
Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer
-
[CrossRef] [PubMed]
-
Gasch, C.; Oldopp, T.; Mauermann, O.; Gorges, T.M.; Andreas, A.; Coith, C.; Muller, V.; Fehm, T.; Janni, W.; Pantel, K. et al. Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer. Mol. Oncol. 2016, 10, 1330–1343. [CrossRef] [PubMed]
-
(2016)
Mol. Oncol
, vol.10
, pp. 1330-1343
-
-
Gasch, C.1
Oldopp, T.2
Mauermann, O.3
Gorges, T.M.4
Andreas, A.5
Coith, C.6
Muller, V.7
Fehm, T.8
Janni, W.9
Pantel, K.10
-
108
-
-
79960453378
-
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients
-
[CrossRef] [PubMed]
-
Aktas, B.; Muller, V.; Tewes, M.; Zeitz, J.; Kasimir-Bauer, S.; Loehberg, C.R.; Rack, B.; Schneeweiss, A.; Fehm, T. Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients. Gynecol. Oncol. 2011, 122, 356–360. [CrossRef] [PubMed]
-
(2011)
Gynecol. Oncol
, vol.122
, pp. 356-360
-
-
Aktas, B.1
Muller, V.2
Tewes, M.3
Zeitz, J.4
Kasimir-Bauer, S.5
Loehberg, C.R.6
Rack, B.7
Schneeweiss, A.8
Fehm, T.9
-
109
-
-
79957894183
-
MRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients
-
[CrossRef] [PubMed]
-
Sieuwerts, A.M.; Mostert, B.; Bolt-de Vries, J.; Peeters, D.; de Jongh, F.E.; Stouthard, J.M.; Dirix, L.Y.; van Dam, P.A.; Van Galen, A.; de Weerd, V. et al. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clin. Cancer Res. 2011, 17, 3600–3618. [CrossRef] [PubMed]
-
(2011)
Clin. Cancer Res.
, vol.17
, pp. 3600-3618
-
-
Sieuwerts, A.M.1
Mostert, B.2
Bolt-De Vries, J.3
Peeters, D.4
De Jongh, F.E.5
Stouthard, J.M.6
Dirix, L.Y.7
Van Dam, P.A.8
Van Galen, A.9
De Weerd, V.10
-
110
-
-
84942917849
-
The first five years of single-cell cancer genomics and beyond
-
[CrossRef] [PubMed]
-
Navin, N.E. The first five years of single-cell cancer genomics and beyond. Genome Res. 2015, 25, 1499–1507. [CrossRef] [PubMed]
-
(2015)
Genome Res
, vol.25
, pp. 1499-1507
-
-
Navin, N.E.1
-
111
-
-
84921793301
-
Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer
-
[CrossRef] [PubMed]
-
Neves, R.P.; Raba, K.; Schmidt, O.; Honisch, E.; Meier-Stiegen, F.; Behrens, B.; Mohlendick, B.; Fehm, T.; Neubauer, H.; Klein, C.A. et al. Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer. Clin. Chem. 2014, 60, 1290–1297. [CrossRef] [PubMed]
-
(2014)
Clin. Chem
, vol.60
, pp. 1290-1297
-
-
Neves, R.P.1
Raba, K.2
Schmidt, O.3
Honisch, E.4
Meier-Stiegen, F.5
Behrens, B.6
Mohlendick, B.7
Fehm, T.8
Neubauer, H.9
Klein, C.A.10
-
112
-
-
84877865227
-
Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing
-
[CrossRef] [PubMed]
-
Heitzer, E.; Auer, M.; Gasch, C.; Pichler, M.; Ulz, P.; Hoffmann, E.M.; Lax, S.; Waldispuehl-Geigl, J.; Mauermann, O.; Lackner, C. et al. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res. 2013, 73, 2965–2975. [CrossRef] [PubMed]
-
(2013)
Cancer Res
, vol.73
, pp. 2965-2975
-
-
Heitzer, E.1
Auer, M.2
Gasch, C.3
Pichler, M.4
Ulz, P.5
Hoffmann, E.M.6
Lax, S.7
Waldispuehl-Geigl, J.8
Mauermann, O.9
Lackner, C.10
-
113
-
-
84891354380
-
Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients
-
[CrossRef] [PubMed]
-
Ni, X.; Zhuo, M.; Su, Z.; Duan, J.; Gao, Y.; Wang, Z.; Zong, C.; Bai, H.; Chapman, A.R.; Zhao, J. et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc. Natl. Acad. Sci. USA 2013, 110, 21083–21088. [CrossRef] [PubMed]
-
(2013)
Proc. Natl. Acad. Sci. USA
, vol.110
, pp. 21083-21088
-
-
Ni, X.1
Zhuo, M.2
Su, Z.3
Duan, J.4
Gao, Y.5
Wang, Z.6
Zong, C.7
Bai, H.8
Chapman, A.R.9
Zhao, J.10
-
114
-
-
84900333051
-
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
-
[CrossRef] [PubMed]
-
Lohr, J.G.; Adalsteinsson, V.A.; Cibulskis, K.; Choudhury, A.D.; Rosenberg, M.; Cruz-Gordillo, P.; Francis, J.M.; Zhang, C.Z.; Shalek, A.K.; Satija, R. et al. Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat. Biotechnol. 2014, 32, 479–484. [CrossRef] [PubMed]
-
(2014)
Nat. Biotechnol
, vol.32
, pp. 479-484
-
-
Lohr, J.G.1
Adalsteinsson, V.A.2
Cibulskis, K.3
Choudhury, A.D.4
Rosenberg, M.5
Cruz-Gordillo, P.6
Francis, J.M.7
Zhang, C.Z.8
Shalek, A.K.9
Satija, R.10
-
115
-
-
84905502594
-
Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells
-
[CrossRef] [PubMed]
-
Dago, A.E.; Stepansky, A.; Carlsson, A.; Luttgen, M.; Kendall, J.; Baslan, T.; Kolatkar, A.; Wigler, M.; Bethel, K.; Gross, M.E. et al. Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells. PLoS ONE 2014, 9, e101777. [CrossRef] [PubMed]
-
(2014)
Plos ONE
, vol.9
-
-
Dago, A.E.1
Stepansky, A.2
Carlsson, A.3
Luttgen, M.4
Kendall, J.5
Baslan, T.6
Kolatkar, A.7
Wigler, M.8
Bethel, K.9
Gross, M.E.10
-
116
-
-
84991499819
-
Mutation analysis of cell-free DNA and single circulating tumor cells in metastatic breast cancer patients with high CTC counts
-
[CrossRef] [PubMed]
-
Shaw, J.A.; Guttery, D.S.; Hills, A.; Fernandez-Garcia, D.; Page, K.; Rosales, B.M.; Goddard, K.S.; Hastings, R.K.; Luo, J.; Ogle, O. et al. Mutation analysis of cell-free DNA and single circulating tumor cells in metastatic breast cancer patients with high CTC counts. Clin. Cancer Res. 2016. [CrossRef] [PubMed]
-
(2016)
Clin. Cancer Res
-
-
Shaw, J.A.1
Guttery, D.S.2
Hills, A.3
Fernandez-Garcia, D.4
Page, K.5
Rosales, B.M.6
Goddard, K.S.7
Hastings, R.K.8
Luo, J.9
Ogle, O.10
-
117
-
-
84983543658
-
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer
-
[CrossRef] [PubMed]
-
Fribbens, C.; O’Leary, B.; Kilburn, L.; Hrebien, S.; Garcia-Murillas, I.; Beaney, M.; Cristofanilli, M.; Andre, F.; Loi, S.; Loibl, S. et al. Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer. J. Clin. Oncol. 2016, 34, 2961–2968. [CrossRef] [PubMed]
-
(2016)
J. Clin. Oncol
, vol.34
, pp. 2961-2968
-
-
Fribbens, C.1
O’Leary, B.2
Kilburn, L.3
Hrebien, S.4
Garcia-Murillas, I.5
Beaney, M.6
Cristofanilli, M.7
Andre, F.8
Loi, S.9
Loibl, S.10
-
118
-
-
67650999875
-
The basics of epithelial-mesenchymal transition
-
[CrossRef] [PubMed]
-
Kalluri, R.; Weinberg, R.A. The basics of epithelial-mesenchymal transition. J. Clin. Investig. 2009, 119, 1420–1428. [CrossRef] [PubMed]
-
(2009)
J. Clin. Investig
, vol.119
, pp. 1420-1428
-
-
Kalluri, R.1
Weinberg, R.A.2
-
119
-
-
2942707848
-
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
-
[CrossRef] [PubMed]
-
Yang, J.; Mani, S.A.; Donaher, J.L.; Ramaswamy, S.; Itzykson, R.A.; Come, C.; Savagner, P.; Gitelman, I.; Richardson, A.; Weinberg, R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117, 927–939. [CrossRef] [PubMed]
-
(2004)
Cell
, vol.117
, pp. 927-939
-
-
Yang, J.1
Mani, S.A.2
Donaher, J.L.3
Ramaswamy, S.4
Itzykson, R.A.5
Come, C.6
Savagner, P.7
Gitelman, I.8
Richardson, A.9
Weinberg, R.A.10
-
120
-
-
84929645752
-
EMT, CTCs and CSCs in tumor relapse and drug-resistance
-
[CrossRef] [PubMed]
-
Mitra, A.; Mishra, L.; Li, S. EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget 2015, 6, 10697–10711. [CrossRef] [PubMed]
-
(2015)
Oncotarget
, vol.6
, pp. 10697-10711
-
-
Mitra, A.1
Mishra, L.2
Li, S.3
-
121
-
-
84944743186
-
Links between cancer stem cells and epithelial-mesenchymal transition
-
[PubMed]
-
Wang, S.S.; Jiang, J.; Liang, X.H.; Tang, Y.L. Links between cancer stem cells and epithelial-mesenchymal transition. Onco Targets Ther. 2015, 8, 2973–2980. [PubMed]
-
(2015)
Onco Targets Ther
, vol.8
, pp. 2973-2980
-
-
Wang, S.S.1
Jiang, J.2
Liang, X.H.3
Tang, Y.L.4
-
122
-
-
84930008414
-
Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines
-
[CrossRef] [PubMed]
-
Kondaveeti, Y.; Guttilla Reed, I.K.; White, B.A. Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines. Cancer Lett. 2015, 364, 44–58. [CrossRef] [PubMed]
-
(2015)
Cancer Lett
, vol.364
, pp. 44-58
-
-
Kondaveeti, Y.1
Guttilla Reed, I.K.2
White, B.A.3
-
123
-
-
84925533652
-
Catabolic metabolism during cancer EMT
-
[CrossRef] [PubMed]
-
Cha, Y.H.; Yook, J.I.; Kim, H.S.; Kim, N.H. Catabolic metabolism during cancer EMT. Arch. Pharm. Res. 2015, 38, 313–320. [CrossRef] [PubMed]
-
(2015)
Arch. Pharm. Res
, vol.38
, pp. 313-320
-
-
Cha, Y.H.1
Yook, J.I.2
Kim, H.S.3
Kim, N.H.4
-
124
-
-
84943246936
-
Metabolic reprogramming: The emerging concept and associated therapeutic strategies
-
[CrossRef] [PubMed]
-
Yoshida, G.J. Metabolic reprogramming: The emerging concept and associated therapeutic strategies. J. Exp. Clin. Cancer Res. 2015, 34, 111. [CrossRef] [PubMed]
-
(2015)
J. Exp. Clin. Cancer Res
, vol.34
, pp. 111
-
-
Yoshida, G.J.1
-
125
-
-
33645748171
-
Regulation of E-cadherin expression by VHL and hypoxia-inducible factor
-
[CrossRef] [PubMed]
-
Esteban, M.A.; Tran, M.G.; Harten, S.K.; Hill, P.; Castellanos, M.C.; Chandra, A.; Raval, R.; O’Brien, T.S.; Maxwell, P.H. Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Res. 2006, 66, 3567–3575. [CrossRef] [PubMed]
-
(2006)
Cancer Res
, vol.66
, pp. 3567-3575
-
-
Esteban, M.A.1
Tran, M.G.2
Harten, S.K.3
Hill, P.4
Castellanos, M.C.5
Chandra, A.6
Raval, R.7
O’Brien, T.S.8
Maxwell, P.H.9
-
126
-
-
33745303045
-
Hypoxia signalling in cancer and approaches to enforce tumour regression
-
[CrossRef] [PubMed]
-
Pouyssegur, J.; Dayan, F.; Mazure, N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006, 441, 437–443. [CrossRef] [PubMed]
-
(2006)
Nature
, vol.441
, pp. 437-443
-
-
Pouyssegur, J.1
Dayan, F.2
Mazure, N.M.3
-
127
-
-
0037478437
-
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
-
[CrossRef]
-
Pennacchietti, S.; Michieli, P.; Galluzzo, M.; Mazzone, M.; Giordano, S.; Comoglio, P.M. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003, 3, 347–361. [CrossRef]
-
(2003)
Cancer Cell
, vol.3
, pp. 347-361
-
-
Pennacchietti, S.1
Michieli, P.2
Galluzzo, M.3
Mazzone, M.4
Giordano, S.5
Comoglio, P.M.6
-
128
-
-
40249113328
-
Direct regulation of TWIST by HIF-1alpha promotes metastasis
-
[CrossRef] [PubMed]
-
Yang, M.H.; Wu, M.Z.; Chiou, S.H.; Chen, P.M.; Chang, S.Y.; Liu, C.J.; Teng, S.C.; Wu, K.J. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat. Cell Biol. 2008, 10, 295–305. [CrossRef] [PubMed]
-
(2008)
Nat. Cell Biol
, vol.10
, pp. 295-305
-
-
Yang, M.H.1
Wu, M.Z.2
Chiou, S.H.3
Chen, P.M.4
Chang, S.Y.5
Liu, C.J.6
Teng, S.C.7
Wu, K.J.8
-
129
-
-
41149105722
-
Mitochondria in cancer cells: What is so special about them?
-
[CrossRef] [PubMed]
-
Gogvadze, V.; Orrenius, S.; Zhivotovsky, B. Mitochondria in cancer cells: What is so special about them? Trends Cell Biol. 2008, 18, 165–173. [CrossRef] [PubMed]
-
(2008)
Trends Cell Biol
, vol.18
, pp. 165-173
-
-
Gogvadze, V.1
Orrenius, S.2
Zhivotovsky, B.3
-
130
-
-
84890464316
-
Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS
-
[CrossRef] [PubMed]
-
Palorini, R.; Votta, G.; Balestrieri, C.; Monestiroli, A.; Olivieri, S.; Vento, R.; Chiaradonna, F. Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS. J. Cell. Biochem. 2014, 115, 368–379. [CrossRef] [PubMed]
-
(2014)
J. Cell. Biochem
, vol.115
, pp. 368-379
-
-
Palorini, R.1
Votta, G.2
Balestrieri, C.3
Monestiroli, A.4
Olivieri, S.5
Vento, R.6
Chiaradonna, F.7
-
131
-
-
84921860188
-
Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma
-
[CrossRef] [PubMed]
-
Shen, Y.A.; Wang, C.Y.; Hsieh, Y.T.; Chen, Y.J.; Wei, Y.H. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma. Cell Cycle 2015, 14, 86–98. [CrossRef] [PubMed]
-
(2015)
Cell Cycle
, vol.14
, pp. 86-98
-
-
Shen, Y.A.1
Wang, C.Y.2
Hsieh, Y.T.3
Chen, Y.J.4
Wei, Y.H.5
-
132
-
-
84876436850
-
Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF
-
[CrossRef] [PubMed]
-
Haq, R.; Shoag, J.; Andreu-Perez, P.; Yokoyama, S.; Edelman, H.; Rowe, G.C.; Frederick, D.T.; Hurley, A.D.; Nellore, A.; Kung, A.L. et al. Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF. Cancer Cell 2013, 23, 302–315. [CrossRef] [PubMed]
-
(2013)
Cancer Cell
, vol.23
, pp. 302-315
-
-
Haq, R.1
Shoag, J.2
Andreu-Perez, P.3
Yokoyama, S.4
Edelman, H.5
Rowe, G.C.6
Frederick, D.T.7
Hurley, A.D.8
Nellore, A.9
Kung, A.L.10
-
133
-
-
84936991599
-
TPO-Induced Metabolic Reprogramming Drives Liver Metastasis of Colorectal Cancer CD110+ Tumor-Initiating Cells
-
[CrossRef] [PubMed]
-
Wu, Z.; Wei, D.; Gao, W.; Xu, Y.; Hu, Z.; Ma, Z.; Gao, C.; Zhu, X.; Li, Q. TPO-Induced Metabolic Reprogramming Drives Liver Metastasis of Colorectal Cancer CD110+ Tumor-Initiating Cells. Cell Stem Cell 2015, 17, 47–59. [CrossRef] [PubMed]
-
(2015)
Cell Stem Cell
, vol.17
, pp. 47-59
-
-
Wu, Z.1
Wei, D.2
Gao, W.3
Xu, Y.4
Hu, Z.5
Ma, Z.6
Gao, C.7
Zhu, X.8
Li, Q.9
|